Login to Your Account



FDA Approvals In November


Monday, December 5, 2011

Company

Drug

Indication


Bristol-Myers Squibb Co.

Erbitux

Head and neck cancer

EUSA Pharma Inc.

Erwinase

Acute lymphoblastic leukemia

Incyte Corp.

Jakafi

Myelofibrosis

IntelGenx Corp.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription